Partner at SFA Consultores, an advisory firm specializing in M&A with extensive experience in the Mexican pharmaceutical sector. We have conducted buy-side mandates, sell-side mandates, and fundraising within the Mexican pharmaceutical ecosystem, involving transactions ranging from $10 to $120 million. We know the local players, and they know us. We believe that nearshoring should bring immense opportunities to players in both the United States and Mexico.